News Breaks |
|
|
| September 5, 2012 |
| 05:55 EDT |  | ARDM, ARDM, SNTA, SNTA, RNN, RNN, FVE, FVE, VICL, VICL, EXEL, EXEL, ENDP, ENDP, CNDO, CNDO, VASC, VASC, ENSG, ENSG, BIIB, BIIB, BDSI, BDSI, VOLC, VOLC | Stifel Nicolaus to host a conference Healthcare Conference 2012 is being held in Boston on September 5-6. |
|
|
News For ARDM;BDSI;BIIB;ENSG;VASC;CNDO;ENDP;EXEL;VICL;FVE;RNN;SNTA;VOLC From The Last 14 Days Check below for free stories on ARDM;BDSI;BIIB;ENSG;VASC;CNDO;ENDP;EXEL;VICL;FVE;RNN;SNTA;VOLC the last two weeks. |
|
|
| May 24, 2013 |
| 07:20 EDT |  | BIIB | Celgene, Gilead, and Biogen could go much higher, says Bernstein
Subscribe for More Information |
|
| May 23, 2013 |
| 08:04 EDT |  | BIIB | Biogen appoints Spyros Artavanis-Tsakonas as Chief Scientific Officer
Subscribe for More Information |
|
| 05:48 EDT |  | VOLC | Volcano announces preliminary results from ADVISE II study
Subscribe for More Information |
|
| May 22, 2013 |
| 10:00 EDT |  | VOLC | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 06:31 EDT |  | VOLC | Volcano upgraded to Overweight from Equal Weight at First Analysis
Subscribe for More Information |
|
| May 21, 2013 |
| 07:24 EDT |  | BIIB | Global Health Care to host a conference
Subscribe for More Information |
|
| 05:44 EDT |  | BIIB | Biogen submits application to FDA for approval of Plegridy in RMS
Subscribe for More Information |
|
| May 20, 2013 |
| 15:57 EDT |  | BIIB | Biogen IMS numbers should not be adjusted down at ISI Group ISI Group confirmed with Biogen that Tecfidera is not captured by IMS and numbers should not be adjusted downward to reflect free drugs dispensed. |
|
| 15:55 EDT |  | VOLC | Volcano added to Best Ideas List at Barrington
Subscribe for More Information |
|
| 07:39 EDT |  | BIIB | Biogen weekly MS drug scripts up 26.5%, says Citigroup Citigroup says weekly scripts for Biogen's multiple sclerosis drug Tecfidera were up 26.5% to 1,621. Citi says the launch of Tecfidera is on track to beat Q2 estimates by a wide margin and it keeps a Buy rating on shares of Biogen. |
| |
| May 17, 2013 |
| 11:53 EDT |  | ENDP | Options with decreasing implied volatility: SGMO ARNA CSC ENDP
Subscribe for More Information |
|
| May 16, 2013 |
| 16:13 EDT |  | VASC | Vascular Solutions files patent infringement complaint against Boston Scientific Vascular Solutions (VASC) announced that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation (BSX). The complaint alleges that Boston Scientific has infringed three patents owned by Vascular Solutions concerning rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter which received 510(k) clearance in March. Vascular Solutions is seeking an injunction against Boston Scientific prohibiting the manufacture and sale of its Guidezilla catheter as well as damages for lost profits and legal costs. |
|
| 10:03 EDT |  | ENDP | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 08:27 EDT |  | ENDP | Endo Health upgraded to Buy from Neutral at Buckingham Buckingham upgraded Endo Health based on attractive risk/reward and expectations for a more detailed strategy from the new CEO, maybe by Q2 results. Price target remains $41. |
|
| 07:29 EDT |  | BIIB | Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. |
|
| May 14, 2013 |
| 15:09 EDT |  | BIIB | Biogen has a conference call hosted by JPMorgan JPMorgan Analysts Meacham and Kasimov host a conference call with CEO George Scangos and CFO Paul Clancy on May 17 at 10 am. |
|
| 07:18 EDT |  | EXEL | BofA/Merrill to host a conference 2013 Health Care Conference is being held in Las Vegas on May 14-16. |
|
| May 13, 2013 |
| 11:12 EDT |  | BIIB | Biogen MS drug scripts grew 38% week-over-week, says Leerink
Subscribe for More Information |
|
| 09:27 EDT |  | ENDP | Endo Health downgraded to Market Perform from Outperform at William Blair
|
|
| 09:25 EDT |  | ENDP | On The Fly: Pre-market Movers
Subscribe for More Information |
| |
|
|
|
|